'Free' cancer drug holds out hope
Earlier this week, the Indian Patent Office ended the monopoly of German drugmaker Bayer over a cancer drug, giving a license to local generic maker Natco Pharma to make and sell the same drug cheaply in India. The move has left the pharma industry split as it opens doors for cheaper drugs in other treatments. But what does it mean for families who have to cough-up a lifetime's saving over a few months for the cancer drug? We find out.
